148 related articles for article (PubMed ID: 12192608)
1. Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia.
Zhang ZJ; Zhang XB; Sha WW; Zhang XB; Reynolds GP
Mol Psychiatry; 2002; 7(7):670-1. PubMed ID: 12192608
[No Abstract] [Full Text] [Related]
2. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
[TBL] [Abstract][Full Text] [Related]
3. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
5. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].
Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817
[TBL] [Abstract][Full Text] [Related]
6. Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia.
Segman RH; Goltser T; Heresco-Levy U; Finkel B; Shalem R; Schlafman M; Yakir A; Greenberg D; Strous R; Lerner A; Shelevoy A; Lerer B
Pharmacogenomics J; 2003; 3(5):277-83. PubMed ID: 14583797
[TBL] [Abstract][Full Text] [Related]
7. Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.
Chen CH; Wei FC; Koong FJ; Hsiao KJ
Biol Psychiatry; 1997 Apr; 41(7):827-9. PubMed ID: 9084902
[No Abstract] [Full Text] [Related]
8. II. Serotonin receptor gene polymorphisms and their association with tardive dyskinesia among schizophrenia patients from North India.
Deshpande SN; Varma PG; Semwal P; Rao AR; Bhatia T; Nimgaonkar VL; Lerer B; Thelma BK
Psychiatr Genet; 2005 Sep; 15(3):157-8. PubMed ID: 16094246
[No Abstract] [Full Text] [Related]
9. Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients.
Zai CC; De Luca V; Hwang RW; Voineskos A; Müller DJ; Remington G; Kennedy JL
Mol Psychiatry; 2007 Sep; 12(9):794-5. PubMed ID: 17767146
[No Abstract] [Full Text] [Related]
10. Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
Zai CC; Tiwari AK; Basile V; De Luca V; Müller DJ; King N; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
Pharmacogenomics J; 2009 Jun; 9(3):168-74. PubMed ID: 19238168
[TBL] [Abstract][Full Text] [Related]
11. Association between clozapine response and allelic variation in the 5-HT2C receptor gene.
Sodhi MS; Arranz MJ; Curtis D; Ball DM; Sham P; Roberts GW; Price J; Collier DA; Kerwin RW
Neuroreport; 1995 Dec; 7(1):169-72. PubMed ID: 8742444
[TBL] [Abstract][Full Text] [Related]
12. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.
Kang SG; Choi JE; An H; Lim SW; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Lee MS; Joe SH; Jung IK; Kim L
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1545-8. PubMed ID: 18602732
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genetic variations in the human melatonin receptor (MTNR1A, MTNR1B) genes and antipsychotics-induced tardive dyskinesia in schizophrenia.
Lai IC; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
World J Biol Psychiatry; 2011 Mar; 12(2):143-8. PubMed ID: 20726823
[TBL] [Abstract][Full Text] [Related]
14. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.
Pae CU; Kim TS; Patkar AA; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
Psychiatry Res; 2007 Sep; 153(1):77-81. PubMed ID: 17582511
[TBL] [Abstract][Full Text] [Related]
15. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
[TBL] [Abstract][Full Text] [Related]
16. No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia.
Lee HJ; Kang SG; Paik JW; Lee MS; Cho BH; Park YM; Kim W; Choi JE; Jung IK; Kim L; Lee MS
Hum Psychopharmacol; 2007 Dec; 22(8):501-4. PubMed ID: 17726725
[TBL] [Abstract][Full Text] [Related]
17. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
[TBL] [Abstract][Full Text] [Related]
18. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism.
Reynolds GP; Zhang ZJ; Zhang XB
Lancet; 2002 Jun; 359(9323):2086-7. PubMed ID: 12086765
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
[TBL] [Abstract][Full Text] [Related]
20. [Antipsychotic-induced weight gain--pharmacogenetic studies].
Olajossy-Hilkesberger L; Godlewska B; Marmurowska-Michałowskal H; Olajossy M; Landowski J
Psychiatr Pol; 2006; 40(5):1009-20. PubMed ID: 17217242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
